Digital Agenda

The SOHO Highlights: State of the Art & Next Questions meeting will be held on October 28, 2020 as a virtual event. The “SOHO Highlights” meeting is designed to provide participants with an overview of the latest advances in hematologic malignancies and a preview of where the field is going next. Investigators from around the world will join the meeting for a day of learning and interactive, virtual discussion with the speakers. Each presentation is 25 minutes followed by a 10-minute, live Questions & Answer session with the audience. Note that the Zoom webinar platform will be utilized to facilitate interaction with attendees.

You may view the SOHO Highlights session line-up in the following Digital Agenda. Those that have registered may select the link to join the session directly. Note that all times in the program are listed in Central Daylight Time (CDT) which is 5 hours behind Coordinated Universal Time (UTC -5).

SOHO Highlights: State of the Art & Next Questions

Wednesday, October 28, 2020
8:00 AM - 8:10 AM (CDT)IntroductionSagar Lonial - Emory University, Winship Cancer Institute
Sagar Lonial View Presentation
8:10 AM - 8:45 AM (CDT)State of the Art & Next Questions: Acute Lymphoblastic LeukemiaHagop Kantarjian - MD Anderson Cancer Center
Hagop Kantarjian View Presentation
8:45 AM - 9:20 AM (CDT)State of the Art & Next Questions: Acute Myeloid LeukemiaAmer Zeidan - Yale Cancer Center
Amer Zeidan View Presentation
9:20 AM - 9:55 AM (CDT)State of the Art & Next Questions: Cellular TherapySergio Giralt - Memorial Sloan Kettering Cancer Center
Sergio Giralt View Presentation
9:55 AM - 10:30 AM (CDT)State of the Art & Next Questions: Chronic Lymphocytic LeukemiaJennifer Brown - Dana-Farber Cancer Institute
Jennifer Brown View Presentation
10:45 AM - 11:20 AM (CDT)State of the Art & Next Questions: Chronic Myeloid LeukemiaMichael Deininger - Huntsman Cancer Institute at the University of Utah
Michael Deininger View Presentation
11:20 AM - 11:55 AM (CDT)State of the Art & Next Questions: Aggressive B-Cell LymphomaSandeep Dave - Duke University School of Medicine
Sandeep Dave View Presentation
11:55 AM - 12:30 PM (CDT)State of the Art & Next Questions: Indolent B-Cell LymphomaRobert Marcus - Leaders in Oncology Care (LOC)
Robert Marcus View Presentation
12:30 PM - 1:05 PM (CDT)State of the Art & Next Questions: T-Cell LymphomaKerry Savage - British Columbia Cancer Agency
Kerry Savage View Presentation
1:35 PM - 2:10 PM (CDT)State of the Art & Next Questions: Mantle Cell LymphomaJonathon Cohen - Emory University, Winship Cancer Institute
Jonathon Cohen View Presentation
2:10 PM - 2:45 PM (CDT)State of the Art & Next Questions: Hodgkin LymphomaDavid Straus - Memorial Sloan-Kettering Cancer Center
David Straus View Presentation
2:45 PM - 3:10 PM (CDT)State of the Art & Next Questions: Multiple MyelomaSagar Lonial - Emory University, Winship Cancer Institute
Sagar Lonial View Presentation
3:20 PM - 3:55 PM (CDT)State of the Art & Next Questions: Myelodysplastic SyndromesGuillermo Garcia-Manero - MD Anderson Cancer Center
Guillermo Garcia-Manero View Presentation
3:55 PM - 4:30 PM (CDT)State of the Art & Next Questions: Myeloproliferative NeoplasmsSrdan Verstovsek - The University of Texas MD Anderson Cancer Center
Srdan Verstovsek View Presentation
4:30 PM - 4:35 PM (CDT)Closing RemarksSagar Lonial - Emory University, Winship Cancer Institute
Sagar Lonial View Presentation